These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12722795)

  • 1. Expression of C-ERBB2 and P65 genes and their protein products in follicular neoplasms of thyroid gland.
    Czyz W; Balcerczak E; Rudowicz M; Niewiadomska H; Pasieka Z; Kuzdak K; Mirowski M
    Folia Histochem Cytobiol; 2003; 41(2):91-5. PubMed ID: 12722795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
    Buergy D; Weber T; Maurer GD; Mudduluru G; Medved F; Leupold JH; Brauckhoff M; Post S; Dralle H; Allgayer H
    Int J Cancer; 2009 Aug; 125(4):894-901. PubMed ID: 19480010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of survivin expression in thyroid follicular adenoma and carcinoma.
    Haghpanah V; Shooshtarizadeh P; Heshmat R; Larijani B; Tavangar SM
    Appl Immunohistochem Mol Morphol; 2006 Dec; 14(4):422-5. PubMed ID: 17122639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular differences between human thyroid follicular adenoma and carcinoma revealed by analysis of a murine model of thyroid cancer.
    Sponziello M; Lavarone E; Pegolo E; Di Loreto C; Puppin C; Russo MA; Bruno R; Filetti S; Durante C; Russo D; Di Cristofano A; Damante G
    Endocrinology; 2013 Sep; 154(9):3043-53. PubMed ID: 23751876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of estrogen receptor Beta expression in follicular thyroid carcinoma predicts poor outcome.
    Heikkilä A; Hagström J; Mäenpää H; Louhimo J; Siironen P; Heiskanen I; Haglund C; Arola J
    Thyroid; 2013 Apr; 23(4):456-65. PubMed ID: 23106428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
    Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
    Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical detection of thyroid transcription factor-1, thyroglobulin, and calcitonin in canine normal, hyperplastic, and neoplastic thyroid gland.
    Ramos-Vara JA; Miller MA; Johnson GC; Pace LW
    Vet Pathol; 2002 Jul; 39(4):480-7. PubMed ID: 12126151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA microarray and miRNA analyses reinforce the classification of follicular thyroid tumors.
    Jacques C; Guillotin D; Fontaine JF; Franc B; Mirebeau-Prunier D; Fleury A; Malthiery Y; Savagner F
    J Clin Endocrinol Metab; 2013 May; 98(5):E981-9. PubMed ID: 23569218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and cellular localization of p8 protein in thyroid neoplasms.
    Ito Y; Yoshida H; Motoo Y; Miyoshi E; Iovanna JL; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Matsuura N; Kuma K; Miyauchi A
    Cancer Lett; 2003 Nov; 201(2):237-44. PubMed ID: 14607339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid pathologic findings in patients with Cowden disease.
    Harach HR; Soubeyran I; Brown A; Bonneau D; Longy M
    Ann Diagn Pathol; 1999 Dec; 3(6):331-40. PubMed ID: 10594284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-G is differentially expressed in thyroid tissues.
    de Figueiredo Feitosa NL; Crispim JC; Zanetti BR; Magalhães PK; Soares CP; Soares EG; Neder L; Donadi EA; Maciel LM
    Thyroid; 2014 Mar; 24(3):585-92. PubMed ID: 24089994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
    Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM
    Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization.
    Katoh R; Kawaoi A; Miyagi E; Li X; Suzuki K; Nakamura Y; Kakudo K
    Mod Pathol; 2000 May; 13(5):570-6. PubMed ID: 10824930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of P161NK4A protein expression in follicular thyroid tumors.
    Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Jarzab B; Sałacińska-Loś E; Kulig A; Włoch J
    Pol J Pathol; 2004; 55(4):143-8. PubMed ID: 15757201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose transporter-1 expression in the thyroid gland: clinicopathological significance for papillary carcinoma.
    Yasuda M; Ogane N; Hayashi H; Kameda Y; Miyagi Y; Iida T; Mori Y; Tsukinoki K; Minematsu T; Osamura Y
    Oncol Rep; 2005 Dec; 14(6):1499-504. PubMed ID: 16273245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase 1 and 2 expressions in the human thyroid gland.
    Lee HM; Baek SK; Kwon SY; Jung KY; Chae SW; Hwang SJ; Woo JS; Lee JY
    Eur Arch Otorhinolaryngol; 2006 Mar; 263(3):199-204. PubMed ID: 16362262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid.
    Soh EY; Duh QY; Sobhi SA; Young DM; Epstein HD; Wong MG; Garcia YK; Min YD; Grossman RF; Siperstein AE; Clark OH
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3741-7. PubMed ID: 9360534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-142-3p down-regulation contributes to thyroid follicular tumorigenesis by targeting ASH1L and MLL1.
    Colamaio M; Puca F; Ragozzino E; Gemei M; Decaussin-Petrucci M; Aiello C; Bastos AU; Federico A; Chiappetta G; Del Vecchio L; Torregrossa L; Battista S; Fusco A
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E59-69. PubMed ID: 25238203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-3 and oncofetal-fibronectin expression in thyroid neoplasia as assessed by reverse transcription-polymerase chain reaction and immunochemistry in cytologic and pathologic specimens.
    Giannini R; Faviana P; Cavinato T; Elisei R; Pacini F; Berti P; Fontanini G; Ugolini C; Camacci T; De Ieso K; Miccoli P; Pinchera A; Basolo F
    Thyroid; 2003 Aug; 13(8):765-70. PubMed ID: 14558920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
    Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
    BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.